Muscarinic receptors in Alzheimer's disease

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 18, Issue SUPPL. B, 1996, Pages 71-75

  Pavia J ^a   De Ceballos, M L ^a   Sanchez De La Cuesta F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MUSCARINIC RECEPTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; BRAIN TISSUE; CONFERENCE PAPER; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; NONHUMAN; RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; BRAIN; GTP-BINDING PROTEINS; HUMANS; RATS; RECEPTORS, MUSCARINIC;

EID: 0029795046     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (39)

1. Davies, P., Maloney, A.J.F. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 1976, 2: 1403.
2. Jope, R.S. Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease. Alzheimer's Dis Rev 1996, 1: 2-14.
3. Adem, A., Nordberg, A., Bucht, G., Winbland, B. Extraneural cholinergic markers in Alzheimer's and Parkinson's diseases. Prog Neuro-Psychopharmacol Biol Psychiat 1986, 10: 247-57.
4. Price, D.L. New perspectives in Alzheimer's disease. Ann Rev Neurosci 1986, 9: 489-512.
5. Butcher, L.L., Wolf, N.J. Cholinergic system in the central nervous system: Retrospection, anatomic distribution and functions. In: Dynamics of Cholinergic Function. Manning, I. (Ed.). Plenum Press: New York 1986, 1-11.
6. McGeer, P.L., McGeer, E.G., Kimura, H., Peng, J.F. Cholinergic neurons and Cholinergic projections in the mammalian C.N.S. In: Dynamics of Cholinergic Function. Hanning, I. (Ed.). Plenum Press: New York 1986, 11-22.
7. Hulme, E.C., Birdsall, N.J.M., Buckley, N.J. Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 1990, 30: 633-73.
8. Goyal, R.K. Muscarinic receptor subtypes. Physiology and clinical implications. New Engl J Med 1989, 321 (15): 1022-5.
9. 2 muscarinic receptors in the cerebral cortex in Alzheimer's disease: An experimental Cholinergic denervation. Science 1985, 228: 1115-7.
10. Araujo, D.M., Lapchak, P.A., Robitaille, Y., Gauthier, S., Quirion, R. Differential alteration of various Cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 1988, 50: 1914-23.
11. 1 muscarinic receptor in Alzheimer's disease: Implications for the failure of cholinergic replacement therapies. Ann Neurol 1991, 29: 256-62.
12. Flynn, D.D., Ferrari-DiLeo, G., Mash, D.C., Levey, A.I. Differential regulation of molecular subtypes of muscarinic receptors in Alzheimer's disease. J Neurochem 1995, 64: 1888-91.
13. 3H-oxotremorine-M binding in normal and Alzheimer's disease parietal cortex: An index of muscarinic receptor-G-protein coupling. Biochem Soc Trans 1989, 17: 202-3.
14. 2 receptor G-protein interactions in the neocortex of patients with Alzheimer's disease. Neurosci Lett 1995, 186: 57-60.
15. Brann, M.R., Ellis, J., Jorgensen, H., Hill-Eubanks, D., Jones, S.P. Muscarinic acetylcholine receptor subtypes: Localization and structure/function. In: Progress in Brain Research, Vol. 98: Cholinergic Function and Dysfunction. Cuello, A.C. (Ed.). Elsevier: Amsterdam 1993, 121-7.
16. Ross, B.M. Signal sorting and amplification through G-protein coupled receptors. Neuron 1989, 3: 141-52.
17. Greenwood, A.F., Powers, R.E., Jope, R.S. Phosphoinositide hydrolysis, Gaq. phospholipase C, and protein kinase C in post mortem human brain: Effects of post mortem interval, subject age, and Alzheimer's disease. Neuroscience 1995, 65: 128-38.
18. Jope, R.S., Song, I., Li, X., Powers, R. Impaired phosphoinositide hydrolysis in Alzheimer's disease brain. Neurobiol Aging 1994, 15: 221-6.
19. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydcl, R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 1993, 10: 243-54.
20. Yakner, B.A., Duffy, L.K., Kirschner, D.A. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science 1990, 250: 279-82.
21. Buxbaum, J.D., Oishi, M., Chen, H.I. et al. Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer βA4 amyloid protein precursor. Proc Natl Acad Sci USA 1992, 89: 10075-8.
22. Nitsch, R.M., Slack, B.E., Wurtman, R.J., Gordon, J.H. Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 1992, 258: 304-7.
23. Sadot, E., Gurwitz, D., Barg, J. Activation of mj muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J Neurochem 1996, 66: 877-80.
24. Itoh, A., Nitta, A., Nadai, M. et al. Dysfunction of cholinergic and dopaminergic neuronal systems in β-amyloid protein-infused rats. J Neurochem 1996, 66: 113-7.
25. 3H]MK801 binding to rat cortical membranes in the presence of glutamate and glycine. J Neurochem 1993, 60: 2296-303.
26. Mattson, M.P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., Rydel, R.E. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 1992, 12: 367-89.
27. Behl, C., Davis, J.B., Lesley, R., Schubert, D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell 1994, 77: 817-27.
28. Perry, E.K., Perry, R.H., Blessed, G., Tomlinson, B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet 1977, 1: 189.
29. White, P., Hilley, C.R., Goodhart, M.J. Neocortical cholinergic neurons in elderly people. Lancet 1977, 1: 668-71.
30. Reisine, T.D., Yamamura, H.I., Bird, E.D., Spokes, E., Enna, S.J. Pre- and post-synaptic neurochemical alterations in Alzheimer's disease. Brain Res 1978, 159: 477-80.
31. Davies, P., Verth, A.M. Regional distribution of muscarinic acetylcholine receptors in normal and Alzheimer's type dementia brains. Brain Res 1978, 138: 385-92.
32. Palacios, J.M. Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia. Brain Res 1982, 243: 173-5.
33. Lang, W., Henke, H. Cholinergic receptor binding and autoradiography in brains of nonneurological and senile dementia of Aizheimer-type patients. Brain Res 1983, 267: 278-80.
34. Candy, J.M., Fairbairn, A.F., Johnson, M., Perry, E.K., Perry, R.H., Smith, C. Hippocampal cholinergic (muscarinic, and putative nicotinic) receptors in human cognitive disorders. Brit J Pharmacol 1986, 88: 359.
35. Rinne, J.O., Laakso, K., Lonnberg, P. Brain muscarinic receptors in senile dementia. Brain Res 1985, 336: 19-25.
36. London, E.D., Waller, S.B. Relationship between choline acetyltransferase and muscarinic binding in aging rodent brain and Alzheimer's disease. In: Dynamics of Cholinergic Function. Manning, I. (Ed.). Plenum Press: New York 1986, 215-24.
37. Kellar, K.J., Whitehouse, P.J., Martino-Barrows, A.M., Marcus, K., Price, D.L. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res 1987, 436: 62-8.
38. Probst, A., Cortes, R., Ulrich, J., Palacios, J.M. Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: An autoradiographic study. Brain Res 1988, 450: 190-201.
39. Smith, C.J., Perry, E.K., Perry, R.H. et al. Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. J Neurochem 1988, 50 (3): 847-56.